AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the spike in flu, respiratory syncytial virus (RSV), and COVID cases across the country. American Medical Association CXO Todd Unger hosts.
Read MoreAMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, shares the latest CDC recommendations, research data, and study findings on: poliovirus in New York, HIV and monkeypox—as well as COVID hospitalization rates and the effectiveness of vaccinations and boosters during Omicron. American Medical Association CXO Todd Unger hosts.
Read MoreThe latest on Omicron subvariants, delays in state-by-state COVID case reporting and more with AMA Director of Science, Medicine and Public Health, Andrea Garcia JD, MPH. American Medical Association CXO, Todd Unger hosts.
Read MoreOmicron summer surges, progress on booster shots for fall, kid’s COVID vaccine rollout, monkeypox vaccines distributed and more discussed by AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH and American Medical Association CXO, Todd Unger.
Read MoreAMA CXO Todd Unger talks with David Rubin, MD, director of PolicyLab at Children’s Hospital of Philadelphia and a professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, about his team’s nationally recognized COVID-19 forecasting model and how it informs new guidance for K-12 educational settings aimed at keeping kids in school.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering developments in COVID hot spots across the nation, the CDC’s clarified stance on masks, and Dr. Fauci’s «five phases of the pandemic.»
Read MoreAMA CXO Todd Unger discusses news from the recent meeting of the CDC’s Advisory Committee on Immunization Practices, or ACIP, with Sandra Fryhofer, MD, AMA’s liaison to ACIP, and a member of ACIP’s COVID-19 Vaccine Workgroup. Updates include new COVID booster recommendations for teens, a shorter booster interval after a Pfizer vaccine series, new additional dose recommendations for immunocompromised children, and what you need to know about Pfizer’s new COVID vaccine formulation for adults. Also reviewing new data about preventing MIS-C (multisystem inflammatory syndrome) in children, as well as recent decision memos from the CDC director.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of Omicron across the U.S. and globally, as well as New York City’s vaccine mandate for private employees.
Read More
Comentarios recientes